Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy–Cramer, Elizabeth R. Gerstner, Xiao Da et al.|Journal of Neuro-Oncology|2016Cited by 82